Literature DB >> 29430761

NOD-like receptor pyrin domain-containing-3 (NLRP3) regulates inflammation-induced pro-labor mediators in human myometrial cells.

Ratana Lim1,2, Martha Lappas1,2.   

Abstract

PROBLEM: Inflammation plays a major role in preterm birth. Nucleotide-binding oligomerization domain-like receptor pyrin domain-containing-3 (NLRP3) plays a role in inflammatory diseases. The aims of this study were to determine the effect of term labor on the expression of NLRP3 in human myometrium and the effect of NLRP3 silencing on pro-labor mediators in myometrial cells. METHOD OF STUDY: NLRP3 expression was assessed in myometrium from non-laboring and laboring women by qRT-PCR and Western blotting. Human primary myometrial cells were transfected with NLRP3 siRNA (siNLRP3), treated with pro-inflammatory cytokines and toll-like receptor (TLR) ligands, and assayed for pro-inflammatory mediators' expression.
RESULTS: NLRP3 expression was higher in myometrium after term spontaneous labor and by TNF, IL1B, fsl-1, and flagellin. In siNLRP3-transfected cells, there was a significant decrease in the expression of pro-inflammatory cytokines (IL1A, IL6), chemokines (CXCL8, CCL2), and adhesion molecules (ICAM1 and VCAM1) stimulated with IL1B, TNF, or TLR ligands; decrease in IL1B-stimulated PTGS2 and PTGFR mRNA expression and PGF2α release; and increase in TNF-stimulated myometrial gel shrinkage as assessed by an in vitro cell contraction assay.
CONCLUSION: NLRP3 is increased with labor in myometrial, and knockdown of NLRP3 is associated with an attenuation of inflammation-induced expression of pro-inflammatory and pro-labor mediators in human myometrium.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NLRP3; inflammation; myometrium; preterm birth; pro-labor mediators

Mesh:

Substances:

Year:  2018        PMID: 29430761     DOI: 10.1111/aji.12825

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  7 in total

Review 1.  Inflammasomes: Their Role in Normal and Complicated Pregnancies.

Authors:  Nardhy Gomez-Lopez; Kenichiro Motomura; Derek Miller; Valeria Garcia-Flores; Jose Galaz; Roberto Romero
Journal:  J Immunol       Date:  2019-12-01       Impact factor: 5.422

2.  Expression and function of macrophage-inducible C-type lectin (Mincle) in inflammation driven parturition in fetal membranes and myometrium.

Authors:  R Lim; M Lappas
Journal:  Clin Exp Immunol       Date:  2019-03-13       Impact factor: 4.330

3.  Inflammasome activation during spontaneous preterm labor with intra-amniotic infection or sterile intra-amniotic inflammation.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Bogdan Panaitescu; Yaozhu Leng; Yi Xu; Adi L Tarca; Jonathan Faro; Percy Pacora; Sonia S Hassan; Chaur-Dong Hsu
Journal:  Am J Reprod Immunol       Date:  2018-09-18       Impact factor: 3.886

4.  Gasdermin D: Evidence of pyroptosis in spontaneous preterm labor with sterile intra-amniotic inflammation or intra-amniotic infection.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Adi L Tarca; Derek Miller; Bogdan Panaitescu; George Schwenkel; Dereje W Gudicha; Sonia S Hassan; Percy Pacora; Eunjung Jung; Chaur-Dong Hsu
Journal:  Am J Reprod Immunol       Date:  2019-09-20       Impact factor: 3.777

5.  Hypomethylation of PRDM1 is associated with recurrent pregnancy loss.

Authors:  Guizhen Du; Mingming Yu; Qiaoqiao Xu; Zhenyao Huang; Xiaomin Huang; Li Han; Yun Fan; Yan Zhang; Ruohan Wang; Shuyu Xu; Xiumei Han; Guangbo Fu; Shuyan Lv; Yufeng Qin; Xinru Wang; Chuncheng Lu; Yankai Xia
Journal:  J Cell Mol Med       Date:  2020-04-29       Impact factor: 5.310

6.  Identification of SMAD3 as a Novel Mediator of Inflammation in Human Myometrium In Vitro.

Authors:  Martha Lappas
Journal:  Mediators Inflamm       Date:  2018-09-27       Impact factor: 4.711

7.  Identification of NLRP3 Inflammation-Related Gene Promoter Hypomethylation in Diabetic Retinopathy.

Authors:  Hui Chen; Xiongze Zhang; Nanying Liao; Yuying Ji; Lan Mi; Yuhong Gan; Yongyue Su; Feng Wen
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.